BOHLIN GAREN G 4
4 · COLLEGIUM PHARMACEUTICAL, INC · Filed May 16, 2024
Insider Transaction Report
Form 4
BOHLIN GAREN G
Director
Transactions
- Exercise/Conversion
Common Stock
2024-05-14$5.73/sh+28,985$166,084→ 73,760 total - Sale
Common Stock
2024-05-14$32.30/sh−28,985$936,311→ 44,775 total - Exercise/Conversion
Stock Option (Right to Purchase)
2024-05-14−28,985→ 0 totalExercise: $5.73Exp: 2025-03-19→ Common Stock (28,985 underlying) - Award
Common Stock
2024-05-16+7,693→ 52,468 total
Footnotes (3)
- [F1]The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.00 to $32.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on May 16, 2025, subject to the director's continued service with the Issuer. The RSUs will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the Issuer, in shares of the Issuer's common stock.
- [F3]The option is fully vested and exercisable.